位置:首页 > 蛋白库 > FBX5B_XENLA
FBX5B_XENLA
ID   FBX5B_XENLA             Reviewed;         384 AA.
AC   Q4V7W2;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 1.
DT   03-AUG-2022, entry version 72.
DE   RecName: Full=F-box only protein 5-B {ECO:0000305};
DE   AltName: Full=Early mitotic inhibitor 1-B;
GN   Name=fbxo5-b; Synonyms=emi1-b;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX   NCBI_TaxID=8355;
RN   [1] {ECO:0000312|EMBL:AAH97694.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Oocyte {ECO:0000312|EMBL:AAH97694.1};
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Regulates progression through early mitosis by inhibiting the
CC       anaphase promoting complex/cyclosome (APC). Binds to the APC activators
CC       cdc20 to prevent APC activation. Can also bind directly to the APC to
CC       inhibit substrate-binding. Required to arrest unfertilized eggs at
CC       metaphase of meiosis II, by preventing their release from metaphase of
CC       meiosis II, through inhibition of APC-dependent cyclin B destruction
CC       leading to stabilization of cyclin B-cdk1 complex activity.
CC       {ECO:0000250|UniProtKB:Q90Z80}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Part of a SCF (SKP1-cullin-F-box) protein ligase complex (By
CC       similarity). Interacts with btrc. Interacts with skp1. Interacts with
CC       cdc20. Interacts with pin1; stabilizes fbxo5 by preventing its
CC       association with btrc in an isomerization-dependent pathway; this
CC       interaction is present during G2 phase and prevents fbxo5 degradation.
CC       Interacts with plk1 (By similarity). {ECO:0000250|UniProtKB:Q90Z80,
CC       ECO:0000250|UniProtKB:Q9UKT4}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q90Z80}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q90Z80}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000250|UniProtKB:Q90Z80}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000250|UniProtKB:Q90Z80}. Note=In
CC       interphase, localizes in a punctate manner in the nucleus and cytoplasm
CC       with some perinuclear concentration. In mitotic cells, localizes
CC       throughout the cell, particularly at the spindle. At metaphase,
CC       localized at mitotic centrosomes. Decreases centrosome localization as
CC       cells progressed through telophase. {ECO:0000250|UniProtKB:Q90Z80}.
CC   -!- DOMAIN: The C-terminal region is required for APC inhibition.
CC       {ECO:0000250|UniProtKB:Q90Z80}.
CC   -!- PTM: Proteolysed; proteolysis is induced by both cyclin B-cdk1 and
CC       cyclin A-cdk1/2 complex through probable phosphorylation. Proteolysis
CC       is inhibited by pin1 during G2. {ECO:0000250|UniProtKB:Q90Z80}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC097694; AAH97694.1; -; mRNA.
DR   RefSeq; NP_001089481.1; NM_001096012.1.
DR   AlphaFoldDB; Q4V7W2; -.
DR   PRIDE; Q4V7W2; -.
DR   DNASU; 734532; -.
DR   GeneID; 734532; -.
DR   KEGG; xla:734532; -.
DR   CTD; 734532; -.
DR   Xenbase; XB-GENE-6255898; fbxo5.L.
DR   OMA; MRASCAF; -.
DR   OrthoDB; 521317at2759; -.
DR   UniPathway; UPA00143; -.
DR   Proteomes; UP000186698; Chromosome 5L.
DR   Bgee; 734532; Expressed in gastrula and 15 other tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005819; C:spindle; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:1990948; F:ubiquitin ligase inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0106061; P:negative regulation of exit from meiosis; ISS:UniProtKB.
DR   GO; GO:0045841; P:negative regulation of mitotic metaphase/anaphase transition; ISS:UniProtKB.
DR   GO; GO:1904667; P:negative regulation of ubiquitin protein ligase activity; ISS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   GO; GO:0051726; P:regulation of cell cycle; ISS:UniProtKB.
DR   InterPro; IPR036047; F-box-like_dom_sf.
DR   InterPro; IPR001810; F-box_dom.
DR   InterPro; IPR044064; ZF_ZBR.
DR   Pfam; PF00646; F-box; 1.
DR   SUPFAM; SSF81383; SSF81383; 1.
DR   PROSITE; PS51872; ZF_ZBR; 1.
PE   2: Evidence at transcript level;
KW   Cell cycle; Cell division; Cytoplasm; Cytoskeleton; Metal-binding; Mitosis;
KW   Nucleus; Reference proteome; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..384
FT                   /note="F-box only protein 5-B"
FT                   /id="PRO_0000258011"
FT   DOMAIN          191..238
FT                   /note="F-box"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         311..359
FT                   /note="ZBR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01220"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          79..106
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        85..106
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         315
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01220"
FT   BINDING         318
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01220"
FT   BINDING         333
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01220"
FT   BINDING         338
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01220"
FT   BINDING         343
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01220"
FT   BINDING         346
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01220"
FT   BINDING         351
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01220"
FT   BINDING         356
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01220"
SQ   SEQUENCE   384 AA;  43171 MW;  DB75043D8244E30B CRC64;
     MMCGFTSNPS PKKLLSKSSA TNVHLEISPV KPDRPCKGYE NVLGSCTTVA KCADLTDDLP
     VHNKENLLHG FNDLERHHDE ENSSLQDSGY SSILQNDSPC QDETDSNVSD IQVRDTPKNL
     MQYQKPFHTL STRCLPILRF EAAMCSTLKK MRKTSKKIDW NAVDDVVCGG NYGLEHLIGK
     SMGLERVDIL AELFHRDFKH LLTKILRHLN AMDLINVIGV STTWRKILQK DNWAYNTYKL
     GCKELCEKRA KVSTHTATRD ESLCRVPLAS VQKVAASSLC TSKKQNKNGG LSNNRHAEFI
     EVAQTLKNDQ SLKACVDCGS PAKYDSYLHR AICTRESCKL DFCTLCSCKY HSSKSCLISK
     PRSYRIPIEP LPGSKKSKQN LRRL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024